EP0551225A1 - Ultra-high-speed extracorporeal ultrasound hyperthermia treatment, method and device - Google Patents

Ultra-high-speed extracorporeal ultrasound hyperthermia treatment, method and device Download PDF

Info

Publication number
EP0551225A1
EP0551225A1 EP93400012A EP93400012A EP0551225A1 EP 0551225 A1 EP0551225 A1 EP 0551225A1 EP 93400012 A EP93400012 A EP 93400012A EP 93400012 A EP93400012 A EP 93400012A EP 0551225 A1 EP0551225 A1 EP 0551225A1
Authority
EP
European Patent Office
Prior art keywords
time
duration
peak power
treatment
frequency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93400012A
Other languages
German (de)
French (fr)
Inventor
Jacques Dory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EDAP International SA
Original Assignee
EDAP International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EDAP International SA filed Critical EDAP International SA
Publication of EP0551225A1 publication Critical patent/EP0551225A1/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00137Details of operation mode
    • A61B2017/00154Details of operation mode pulsed

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Surgical Instruments (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

An extracorporeal ultra-high-speed ultrasound hyperthermia treatment method consisting in transmitting and focussing on the tumor ultrasound wave trains at frequencies between 0.5 and 10 MHz with peak electric powers which may reach 20 Kw or more, the parameters which define the concentration of the treatment beam in the focal spot and the power being determined so that, irrespective of the depth and the nature of the tissue, the treatment time is in the order of that enabling significant destruction, preferably total destruction, of the target during the linear part of a curve showing the temperature increase as a function of time.

Description

    BACKGROUND OF THE INVENTION Field of the invention
  • The present invention concerns an ultra-high-speed extracorporeal ultrasound hyuperthermia method and treatment device.
  • Description of the prior art
  • It is known, in particular from RE 33,590, to use a focussed ultrasound beam to cause extremely localized heating of biological tissue in order to destroy tumors. The beam is transmitted in the form of periodic wave trains having a predetermined frequency peak power and duration.
  • In the device described in the patent referred to above, the beam high frequency is comprised between 0.5 and 5 MHz, for example, the lower frequencies being used to destroy the deeper structures within the body and the electric peak power which excites the transducer is comparatively low (10 to 100 watts, the higher powers being used to destroy the deeper structures).
  • These wave trains, the duration of each of which is about 1 second, are separated by intervals of about 1/10 second during which it is possible to carry out real time (usually type B) ultrasound scanning to relocate the focus relative to the target (which is affected by natural movements of the tissues caused by breathing) or to examine the damage sustained by the tissues in the treated area.
  • With the power level and frequencies employed - which depend on the depth of the target area - the target temperature is increased to approximately 45°C, a temperature which is sufficiently high in principle to destroy malignant cells. It has been thought previously that an excessive increase in the temperature of the target area could cause serious burns in the surrounding area as the result of thermal diffusion.
  • As a result, treatment times are relatively long, possible several tens of minutes or even several hours.
  • The invention is based on the discovery that increasing the peak power of the waves used by a factor of 10 to 200 or more, depending on the depth and the absorbing power of the target area, makes it possible, by causing an ultra-high-speed temperature rise, to significantly reduce the effects of thermal diffusion and to destroy the target area in time periods in the order of one second or less.
  • SUMMARY OF THE INVENTION
  • It is an object of the invention to provide a method of effecting an ultra-high-speed treatment of a region of a subject located at a known depth within the body with compressional wave energy derived from ultrasonic transducer means for applying to said region a focussed beam transmitted in the form of periodic bursts of oscillations having a predetermined frequency and a predetermined peak power, each burst having a predetermined duration and the successive burst being separated by time intervals, said method comprising the steps of :
    • effecting tests with said ultrasonic transducer means on a target located at said depth within the body for determining the curve of temperature increase of said target as a function of the time of application of said compressional wave energy, said time curve having a quasi-linear portion which starts at time zero and ends at a time to ;
    • determining the particular peak power of said burst of oscillations which will provide at least a substantial destruction of said region of the subject in a single burst of oscillations having a duration equal to the time to and selecting a peak power of treatment at least equal to said particular peak power and a duration of the treatment burst at most equal to the time to.
  • It is another object of the invention to provide a method of the type above referred to, in which the frequency as well as the diameter of the transmitting surface of the ultrasonic transducer means and the diameter of the focal spot are advantageously determined and selected according to the nature and depth of the target so that the concentration of the beam is maximized and the power is then determined for a selected value of the frequency and of the selected diameters so that the target is destroyed at a temperature much larger than that which was generally used in prior art and in a time period much shorter.
  • Tests effected by the applicant have shown that the construction of the device which implements this method, requiring the implementation of means for quasi-continuous transmission of compressional wave energy at very high peak powers, can minmize the destruction of healthy cells whilst enhancing the effectiveness with which the target is destroyed, in particular as the result of an additional mechanical destructive effect on the cells of the target, so providing a new localized ultrasound hyperthermia treatment technique justifying subsequent use in this description of the term "ultra-high-speed hyperthermia treatment".
  • According to another aspect of the invention, the ultra-high-speed hyperthermia treatment method provides significantly improved echographic examination of changes to the target during treatment.
  • Therefore, it is a further object of the invention to provide a method of ultra-high-speed hyperthermia treatment in which the examination of the target is carried out by type A or B echography during interruptions in the treatment beam at a given rate such that the A echogram or the B image has time to undergo detectable modifications (which could mean a few tenths of a second in ultra-high-speed hyperthermia treatment) which are not masked by spurious modifications caused by movements of the wave trains (as is the case in practice with prior art hyperthermia treatment techniques).
  • The invention also has for its object specific type A or B echographic methods which facilitate the ultra-high-speed detection of change sustained by the target so that treatment can be terminated as soon as the target is destroyed.
  • Other features and the advantages of the invention will be more clearly apparent from the following description in which the ultra-high-speed echographic detection methods are described first, to facilitate the subsequent description of the treatment method and of the construction of the specific features of the ultra-high-speed hyperthermia treatment device.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • Figure 1 is a block diagram showing an ultra-high-speed hyperthermia treatment device provided with means for ultra-high-speed detection of change to the target during treatment ;
    • Figure 2 is a timing diagram showing the operation of said detection means ;
    • Figures 3a and 3b illustrate tables indicating the global concentration k and the rate dT/sec of temperature rise as a function of frequency F, for given characteristic parameters of the transducer means.
    • Figure 4 shows curves representing the temperature increase of a biological tissue as a function of heating time ; and
    • Figure 5 is a graph illustrating the time of destruction of a biological tissue as a function of the heating temperature.
    DETAILED DESCRIPTION OF THE INVENTION
  • Figure 1 is a block diagram of a known type echography device comprising a real time probe 1 including a piezoelectric transducer element 12 which is oscillated by an electric motor 13 through a mechanical transmission system represented by the chain-dotted line.
  • For example, this probe may be as described in US patent No. 4,418,698 granted December 6, 1983 in respect of : "Mechanical sector scanned echographic probe".
  • The piezo-electric element 12 is excited by a pulse generator 2 and the motor is controlled by a sawtooth scanning signal generator (producing the waveform (A) shown in figure 2) to scan a sector of the region to be treated, the scan passing through the focus of the treatment beam emitter.
  • The echo pulses reflected from biological structures are amplified by a receiver 4 whose output is connected to an analog-to-digital converter 5.
  • An electronic switch 6 connects the output of the converter 5 to one or other of two memories 61 and 62. Switching occurs on each scan, the switch 6 being connected to an appropriate output of the sawtoolth generator 3 for this purpose.
  • In each memory, addressing of the writing operation is effected in a known manner according to the angular position of the beam emitted by the probe and the time elapsed since the start of each pulse transmission, so that a complete image of the treated area is written into one of the two memories on each scan.
    The memories are also read in a known way and the resulting signals are fed to a digital subtractor through a switch 71 which reverses the connection between its inputs E1 and E2 and its outputs S1 and S2 on each scan (being connected to the appropriate output of the generator 3 to this end).
  • If no inversion were applied, the subtractor, which computes the difference between the serial digits which define the successive points of the two images, would subtract the current image from the previous image and then the previous image from the current image, and so on, the inversion being required so that the previous image is always subtracted from the current image in each scan.
  • The output of the subtractor 7 is connected to a digital-to-analog converter 72 which supplies a voltage for modulating the brightness of the cathode ray tube of a display device 8.
  • The output S2 is connected to a second digital-to-analog converter 73. A potentiometer 74 provides a variable mix of the output voltage of the converter 72, representing the differential image, and the output voltage of the converter 73, representing the latest image stored.
  • The operator can then observe either the conventional image of the treated area, enabling a preliminary identification of the strucutres concerned, or the differential image, enabling him to observe how the structures change during the treatment.
  • As the treatment uses extremely high peak powers, the images cannot be formed during emission of the treatment beam, the energy of which, reflected from the structures concerned, is sufficient to "dazzle" the echographic transducer. The effect of this can continue for one or more microseconds after the end of emission. It is therefore necessary to emit wave trains separated by gaps (waveform (B) in figure 20) slightly longer than the duration of an echographic scan, which might be 1/20 s, for example, and to synchronize the latter with the emission.
  • It is obviously also necessary for the images to be formed at a sufficiently high rate for natural movement of the tissue as a result of breathing not to introduce excessive differences between two successive images, which would mask the differential effect resulting from the modification of the structures due to the treatment. To give an example, the emission time could be chosen to obtain an image every 0.5 s at least. This implies that the peak power of the treatment emission be sufficient for significant destruction of the target area cells to occur in a few tenths of a second.
  • Figure 2 shows at (C) the intervals in which the memory 61 is written,at (D) the intervals in which the memory 62 is written, at (E) the intervals in which the memory 61 is read, at (F) the intervals in which the memory 2 is read and at (G) and (H) the resulting states of the outputs S1 and S2. The numbers of the images in memory are shown. This shows that the previous image is always subtracted from the current image.
  • Referring again to figure 1, the power transducer T, symbolically represented as a spherical cup on which piezo-electric elements are placed, is energized by the treatment beam emitter 10. The transducer is advantageously as described in RE 35,590 and the probe 1, although shown separately, would in practice be attached to the cup, disposed at its center and oriented along its axis, as explained in the aforementioned patent.
  • Figure 1 also shows units that are not used in the embodiment of the invention described thus far, but only in a modified embodiment now to be described.
  • These units are a variable ratio frequency divider 9, an AND gate 11, a memory 12, a display device 13 and a switch 14.
  • When the switch 14 is in position a, the divider 9 is connected to the sawtooth generator 3, which is adapted to provide a synchronization signal when the axis of the probe passes through the focus of the treatment beam emitter ( the center of the sphere of which the cup T constitutes a portion). The division ratio of the divider is then set to a value between 1 and 5, for example.
  • It therefore provides every N scans a short signal applied to the power emitter 10 and which disables it for its duration of approximately 1 ms.
  • The short signal is also applied to the gate 11 which is therefore enabled for 1/1 000 s and passes to the memory 12 the digital signal from the converter 5.
  • The memory 12 has the time to acquire information representing a scanning line, the duration of which is in the order of only 0.2 ms (as compared with 0.2 to 0.02 s to acquire a complete image).
  • Thus in this modified embodiment the treatment beam will be interrupted for one ms during the duration of the treatment beam pulses, and this will occur every 1/20 s, for example, resulting in only a very slight reduction (2% for example) of the mean power as compared with an uninterrupted treatment beam.
  • The line acquired "on the fly" in this way, every 1 to 5 scans, passes through the focus. This method finally uses a type A echograpy, and the information collected in one direction only is sufficient. An equivalent result could be obtained by immobilizing the probe in a particular direction through the target.
  • The echo signals stored in the memory 12 are read out at a rate of 50 Hz, for example, and displayed continuously on the screen of the device 13.
  • This reading frequency promotes visual comfort.
  • In this modified method, the eye of the operator performs the equivalent of the digital subtraction of the information collected during treatment, at a rate such that it can perceive changes in the amplitude of the ultrasound scan.
  • It should be understood that using a type B ultrasound probe to obtain type A echograms has the advantage of enabling the same probe to be used for type B ultrasound scanning before a target is treated (here the term "target" refers to a part of the tumor which is exactly the same size as the focal spot, and complete treatment of the tumor will entail focussing the beam onto the various target areas constituting it in succession), to locate said target area as described in the previously mentioned RE 33,590. A relocation can even be carried out by the same probe for type B ultrasound scanning during the treatment of a target, by interrupting the treatment beam for a sufficient time to obtain an image (1/20 s).
  • The ultra-high-speed hyperthermia treatment method will now be explained with reference to figures 3a, 3b, 4 and 5.
  • The table illustrated in figure 3a corresponds to a power transducer T having a spherical transmitting surface, with a focal distance of 10 cm and an aperture angle of 60° of the beam.
  • The values of the global concentration factor k = k a x k g
    Figure imgb0001
    have been calculated by the applicant for a power transducer shaped as a spherical cup having a given first diameter D and producing a focal spot having a given second diameter d, from which the geometrical concentration factor k g = D/d
    Figure imgb0002
    is known by calculating the attenuation factor ka, starting from known experimental data which show that attenuation of acoustic waves in a biological tissue other than a bone of a tissue which contains air, is about 1dB per MHz and per cm of propagation path within the tissue.
  • The rate dT/sec. of a temperature rise as a function of frequency F has been calculated, for a given diameter d of the focal spot and a given entry diameter of the beam into the body, for an aperture constant angle of the beam and a transmitted acoustic peak power of 1 Kw, by making the assumption that the energy losses in the tissue which are due to absorption amount to 1% of the transmitted power, other losses, amounting to 9% of the transmitted power, being bound to multiple reflection upon the cell surfaces. Thus, one has been able to calculate the fraction of the power losses which is absorbed and is converted into heat within the tissue and therefore, the rate of temperature rise.
  • It should be noted that available prior art data generally indicate absorption losses higher than 1% (for instance between 2-3%). It therefore results from the assumption made by the applicants that the calculated ratio of temperature rise is most probably lower than that which will actually be obtained. This may lead to an overevaluation of the calculated peak power required, but overevaluation is better than underevaluation, which would lead to an increased risk of thermal diffusion in the tissues environing the target.
  • Figure 3a corresponds to a focal length of 10 cm and an entry diameter of 10 cm, whereas figure 3b corresponds to a focal length of 1.5 cm and an entry diameter of 1.5 cm.
  • The operating frequency F will be selected as follows : First, the focal length which is nearer from the depth of the target within the body (i.e. the distance along the beam path between skin and tumor) will be selected.
  • As an example; for a target depth of about 10 cm, a focal length of 10 cm will be selected and therefore, the table of figure 3a will be used for frequency calculation.
  • The selected frequency will be that which both corresponds to the maximum value of k and to the maximum rate of temperature rise. Figure 3a shows that F = 1 Mhz.
    Figure imgb0003
  • For a focal length of 1.5 cm (which will be selected for tumors of small depth), the table of figure 3b shows that the selected frequency will be 6 MHz.
  • It should be noted that the above method of selecting the optimal operating frequency is based on the hypothesis that thermal diffusion and cooling of the tissue, due to blood circulation, are negligibly small, these phenomena not having been taken into account in the applicant's calculations.
  • In fact, these phenomena could have - if the applicants's method were not used - a very important effect when a heat source of small volume, as a focal spot of 1.5 mm of diameter is used. However, as the applicant's method effects heating only during the quasi-linear part of the curve of temperature increase as a function of the heating time, it finally results that nearly the whole of the energy which is absorbed by the target is used for heating it and therefore, the losses due to the above mentioned phenomena are actually negligibly small with respect to the absorbed power.
  • The curves of figure 4 show, for a small heat source (in this example a small diameter focal spot), the experimentally determined increase in the temperature T of the area acted on by an ultrasound beam as a function of the application time, for two different applied power levels (curves II and II).
  • The temperature rise is seen to be quasi-linear over a time to which is substantially the same for both curves, but corresponds to different temperatures, respectivly To1 and To2. After a ceiling which corresponds to an equality between the thermal losses and the supply of heat, and which is reached after a time of 5 to and corresponds to a temperature of about 3 To1 for curve I and 2.6 To2 for curve II, the temperature T then rapidly decreases.
  • Note that to is independent of the applied power and is in direct proprotion to the focal spot diameter. In the experiments yielding the curves shown in figure 4, the frequency is 1 MHz, the focal spot diameter is 1.5 mm and to = 0.5 s. The applicant has determined similar curves from tests carried out for various values of the operating frequency and of the focal spot diameter, in particular for the values which are indicated in the tables.
  • The applicant's method, consisting in selecting a peak power such that a total or at least a substantial destruction of the target cells will be obtained after a time of to at most, it will result, according to the applicant's discovery, that minimal damage will be caused to tissues in the area surrounding the target.
  • It further results that the total quantity of heat energy required by the method for destroying the target is much smaller than in prior art methods.
  • These experimental results can be explained by the fact that, in the linear region of the curve, losses by diffusion are negligible in comparison with the heat input. Beyond this point, the losses are proportional to the temperature gradient between the target and the surrounding tissue, and so increase rapidly until they are equal to the heat input (at the ceiling temperature). When the input of heat is terminated, the temperature of the target decreases exponentially to a value at which there is substantially no more destruction after a time in the order of 3 to 6 x to in these experiments. This time (in the order of 1.5 to 3 s in this case) will substantially define the minimum gap between two successive wave trains of the treatment wave, so that all wave trains are subject to minimal losses by diffusion.
  • However, in practice, it has been found that a preferred value of the gap is at least ten times the wave train duration.
  • In figure 2, where the wave train duration is sligthly less than 0.5 s, a value chosen because it corresponds to to, the successive wave trains, separated by only 0.05 s, will be applied to different targets in the tumor, a single wave train being sufficient to compare the reflective state of each target before and after it is applied.
  • It is known that the time t to destroy tumor cells is inversely proportional to the temperature T to which they are subjected from a threshold value Ti of the latter which is 40°C, for example. For T = 58°C,
    Figure imgb0004
    the graph of figure 5 shows that the value of t is in the order of 0.5 s. The application time t is substantially halved for each increase in temperature of 10°C above 43°C, so that it is divided by 4096 on increasing from 58°C to 70°C, for example.
  • It should be noted that, as the tissues will be destroyed in 0.5 seconds only if the temperature of 58° has been reached in a time substantially lower than 0.5 s, a value of to equalling half of the time indicated by the graph of figure 5 will preferably be selected. Therefore, a value of t o = 0.25 s
    Figure imgb0005
    will be selected. A temperature of 70°C will then be reached at the end of the power burst, i.e. in 0.25 s.
  • The table of figure 3a shows that dT/sec = 33.97
    Figure imgb0006
    for an acoustic peak of 1 Kw. Therefore, to raise the target temperature approximately 32°C above normal in 0.25 s, representing a rate of temperature increase of 138°C/s, the power should be multiplied by the ratio 138/33.97 = 4, it being obvious that the rate of temperature rise is substantially proportional to the heating power when one operates in the quasi-linear part of the curve.
  • The factor of power conversion of the transducer T being about 1/4, and account being taken of the transmission losses along the path of the beam, an electric peak power of about 20 Kw shall finally be used.
  • With the view of avoiding too large a power density on the piezoelectric transducer element which comprises transducer T, the latter will consist of a spherical cap having for instance a diameter of 300 mm and a focal length of 300 mm with an aperture angle of 60°.
  • Selection of such a focal length results from a compromise between the required condition that the aperture angle should be as large as possible so as to concentrate acoustic energy at the focus and the requirement that the entry surface of the beam within the body should be comparatively small, for avoiding an interference of the beam with bones, air pockets or other obstacles to the propagation of ultrasounds.
  • In a practical embodiment, as the focal length of the apparatus will not be variable, the operator will displace the transducer for bringing it to a distance from the skin equalling the target depth, thus obtaining coincidence between the target and the focal spot.
  • The attenuation of ultrasounds in the coupling water medium being negligibly small, the tables of figures 1a and 1b remmain valid.
  • A single apparatus, having a maximum electric peak power of 20 Kw, and the power of which is controllable, and having a wave train duration which may be varied between 0.01 and 1 s for instance, will enable the practician to treat targets of any depth ranging from a few cm to 10-12 cm. A graph will be provided by the manufacturer to indicate the optimal duration of the wave train for each tumor, as a function of its depth.
  • The power may be adjusted, it being understood that the deeper tumors will require the maximum power.
  • However, it might be preferred to manufacture three different devices for treating three respective ranges of target depths.
  • For example, for an emitted power of 1 Kw, respective focal lengths of 10 and 12 cm and respective tissue entry diameters of 10 and 12 cm, the optimum frequency determined from the tables is 1 Mhz, yielding temperature increase rates of 33.97°C/s and 21.43° C/s respectively. An electric power of 20 Kw will then be used as explained hereinabove.
  • For focal lengths of 3 and 5 cm and respective entry diameters of 3 and 5 cm, the respective optimal frequencies will be 3 and 1.5 MHz and the respective rates of temperature increase will be 384.89°C/s and 135.91 C/s. Powers of between 2 and 5 Kw will then for instance be used.
  • For a focal length of 1.5 cm, the optimum frequency will be 6 MHz and the temperature increase 1 539.57°C, requiring in practice a power level in the order of 1 Kw.
  • Generally speaking, the peak powers used in ultra-high-speed hyperthermia treatment, especially to treat deep tumors, require that special provisions are embodied in the construction of the device. In particular, it is necessary to use piezo-electric ceramic materials capable of supporting such high peak powers and of cooling quickly. Forced cooling arrangements may be needed. The supply of power to the electrical generator may require the use of auxiliary power supplies.
  • Note that the optimum power values specified should not be significantly exceeded, to avoid the risk of lesions affecting the surrounding tissue. It has been shown that the diameter of the area within which the temperature rise resulting from the diffusion of heat energy accumulated in the focal region at the moment when appliction of power is terminated remains sufficiently high to destroy the cells relatively quickly increases in proportion to the square root of the temperature increase in the focal region, which increase is in turn proportional to the power.
  • Finally, note that at the powers indicated the ultrasound beam is progressively transformed to a significant degree during its propatation, the result being the appearance of thermic components at higher frequencies than those of the original beam.
  • These high frequency components are more strongly absorbed by the tissue and therefore have greater thermal effect. Moreover, experiments made by the applicant have shown that the risk of burning the skin is decreased.
  • The frequencies and powers chosen enable the beam to pass with little damage through the outer layers of tissue and to produce a thermal effect at the focal spot.
  • The beam additionally has a mechanical effect which complements its thermal effect for increased treatment efficiency.

Claims (19)

  1. A method of effecting an ultra-high-speed hyperthermia treatment of a region of a subject located at a known depth within the body, with compressional wave energy derived from ultrasonic transducer means for applying to said region a focussed beam transmitted in the form of periodic bursts of oscillations having a predetermined frequency and a predetermined peak power, each burst having a predetermined duration and the successive bursts being separated by time intervals, said method comprising the steps of :
    a) effecting tests with said ultrasonic transducer means on a target located at said depth within the body for determining the curve of temperature increase of said target as a function of the time of application of said compressional wave energy, said curve having a quasi-linear portion which starts at time zero and ends at a time to;
    b) determining the particular peak power of said burst of oscillations which will provide at least a substantial destruction of said region of the subject in a single burst of oscillations having a duration equal to the time to and
    c) selecting a peak power of treatment at least equal to said particular peak power and a duration of the treatment bursts at most equal to the time to.
  2. The method of claim 1, wherein said frequency is substantially equal to 1 Mhz and an electric peak power of at least 10 Kw is applied to said ultrasonic transducer means.
  3. The method of claim 1, wherein said frequency is comprised between 1.5 and 3 MHz and an electric peak power comprised between 5 Kw and 2 Kw is applied to said ultrasonic transducer means.
  4. The method of claim 1, wherein said frequency is substantially equal to 6 MHz and an electric peak power of a few hundred watts is applied to said ultrasonic transducer means.
  5. The method of claim 1, wherein said frequency is substantially equal to 1 MHz and an electric peak power ranging from 10 to 20 Kw is applied to said ultrasonic transducer means.
  6. The method of claim 1, wherein said duration is comprised between 0.5 and 3 seconds.
  7. The method of claim 1, wherein said duration is comprised between 0.01 and 1 second.
  8. The method of claim 1, wherein said time intervals each equal at least ten times said duration.
  9. The method of claim 1, wherein said duration substantially equals half of the the time to.
  10. The method of claim 1, wherein said transducer means has a predetermined focal length, a circular transmitting surface and a circular focal spot having first and second predetermined respective diameters, said method comprising the further steps of :
    d) calculating, as a function of said frequencies and for a plurality of different focal lengths and a peak power of said compressional wave energy equalling 1 Kw, tables of the global concentration factor k = k a x k g
    Figure imgb0007
    of the focussed beam, ka being the attenuation factor of the compressional wave energy along the beam path between said transmitting surface and said focal spot and kg being the ratio between said first and second diameters ;
    e) selecting from said plurality of different focal lengths the focal length value which is nearer from the depth of said region and, for said nearer value, selecting from the table the maximum value of said global concentration factor, said maximum value corresponding in the table to a particular frequency ;
    f) selecting a frequency of treatment substantially equalling said particular frequency.
  11. The method of claim 10, wherein said tables further comprise calculated values of the temperature rise per unit of time of a region of a subject to which said compressional wave energy is applied and said method comprises the further step of
    g) calculating, from datas available in medical litterature and which provide different values of the time of lethal exposure of animal or human living tissues to heat, as a function of the temperature which said tissues are brought to, the value of the temperature rise per unit of time to which the tissues should be subjected for destroying them in the duration of the treatment burst which has been selected in step c). and
    h) calculating the ratio between the value of the temperature rise per unit of time which has been calculated in step g) and the value of the temperature rise per unit of time which is given by the table for the focal lenght selected in step e). and the particular frequency selected in step f) and wherein the determination of the particular peak power in step b) is carried out by multiplying 1 Kw by the ratio calculated in step h).
  12. The method of claim 10, wherein said transmission surface has a diameter of 300 mm, said focal spot a diameter of 1.5 mm, said focal distance is 300mm and said path has an aperture angle of 60°.
  13. Apparatus for ultrasonically effecting an ultra-high-speed hyperthermia treatment of a subject volume, said apparatus comprising piezoelectric power transducer means having a focussing surface and electric power generator means connected to said transducer means and applying to said generator means periodic wave trains having an adjustable peak power the maximum value of which is substantially comprised between 10 and 20 Kw and an adjustable duration comprised between 0.5 and 3 sec.
  14. The apparatus of claim 13, wherein said adjustable duration is comprised between 0.01 and 1 sec.
  15. The apparatus of claim 13, further comprising image forming means for echographic examination of damage to the subject volume during treatment and means for comparing two consecutive images of the subject volume respectively formed before and after application of at least one of said wave trains.
  16. The apparatus of claim 15, wherein said comparing means comprise means for storing the consecutive images in the form of digital information and means for forming a differential image by subtracting the stored information point by point.
  17. The apparatus of claim 16, wherein said means for storing the consecutive images comprise first and second digital memories, each having an output, sai means for forming a differential image comprise subtractor means having first and second inputs, and the apparatus further comprises switch means for successively connecting the output of the first memory to the first input of the subtractor means and the output of the second memory to the second input of the subtractor means during the formation of a first image and the output of the first memory to the second input and the output of the second memory to the first input during the formation of a second consecutive image.
  18. The apparatus of claim 16, further comprising means for superposing a stored image on the differential image.
  19. The apparatus of claim 13, further comprising echographic means, including a B-scan probe, for effecting an angular sector scan of the target with a scanning beam and receiving echoes from the target, means receiving said echoes and displaying A echograms of the successive scanning lines and means for producing a pulse signal larger than the duration of scanning of a line and smaller than the duration of a full scan of the target, at each time when the scanning line passes through the focus of said power tranducer means, a memory unit and divider means, responsive to 1/N of the pulse signals, N being an integer, for disabling said electric power generator means and writing said echogram in said memory.
EP93400012A 1992-01-07 1993-01-05 Ultra-high-speed extracorporeal ultrasound hyperthermia treatment, method and device Withdrawn EP0551225A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9200051A FR2685872A1 (en) 1992-01-07 1992-01-07 APPARATUS OF EXTRACORPOREAL ULTRASONIC HYPERTHERMIA WITH VERY HIGH POWER AND ITS OPERATING METHOD.
FR9200051 1992-01-07

Publications (1)

Publication Number Publication Date
EP0551225A1 true EP0551225A1 (en) 1993-07-14

Family

ID=9425411

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93400012A Withdrawn EP0551225A1 (en) 1992-01-07 1993-01-05 Ultra-high-speed extracorporeal ultrasound hyperthermia treatment, method and device

Country Status (8)

Country Link
US (1) US5354258A (en)
EP (1) EP0551225A1 (en)
JP (1) JPH0678944A (en)
CN (1) CN1076128A (en)
BR (1) BR9300021A (en)
CA (1) CA2086772A1 (en)
FR (1) FR2685872A1 (en)
IL (1) IL104216A0 (en)

Families Citing this family (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US5897553A (en) 1995-11-02 1999-04-27 Medtronic, Inc. Ball point fluid-assisted electrocautery device
US6409722B1 (en) 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
GB2303552A (en) * 1995-07-24 1997-02-26 Gar Investment Corp Ultrasound apparatus for non invasive cellulite reduction
NL1003024C2 (en) 1996-05-03 1997-11-06 Tjong Hauw Sie Stimulus conduction blocking instrument.
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US6805128B1 (en) 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US6840936B2 (en) 1996-10-22 2005-01-11 Epicor Medical, Inc. Methods and devices for ablation
US6719755B2 (en) 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
DE69840444D1 (en) * 1997-05-23 2009-02-26 Prorhythm Inc DISMISSABLE FOCUSING ULTRASOUND APPLICATOR OF HIGH INTENSITY
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
US8709007B2 (en) 1997-10-15 2014-04-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Devices and methods for ablating cardiac tissue
US6706039B2 (en) 1998-07-07 2004-03-16 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US6537248B2 (en) 1998-07-07 2003-03-25 Medtronic, Inc. Helical needle apparatus for creating a virtual electrode used for the ablation of tissue
US8308719B2 (en) 1998-09-21 2012-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
WO2001005306A1 (en) 1999-07-19 2001-01-25 Epicor, Inc. Apparatus and method for ablating tissue
US7229469B1 (en) 1999-10-02 2007-06-12 Quantumcor, Inc. Methods for treating and repairing mitral valve annulus
US6409720B1 (en) 2000-01-19 2002-06-25 Medtronic Xomed, Inc. Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US8221402B2 (en) 2000-01-19 2012-07-17 Medtronic, Inc. Method for guiding a medical device
US6595934B1 (en) 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6413254B1 (en) 2000-01-19 2002-07-02 Medtronic Xomed, Inc. Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6692450B1 (en) 2000-01-19 2004-02-17 Medtronic Xomed, Inc. Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same
US7706882B2 (en) 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US6361531B1 (en) 2000-01-21 2002-03-26 Medtronic Xomed, Inc. Focused ultrasound ablation devices having malleable handle shafts and methods of using the same
WO2003024349A1 (en) 2001-09-05 2003-03-27 Tissuelink Medical, Inc. Fluid-assisted medical devices, systems and methods
US8048070B2 (en) 2000-03-06 2011-11-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices, systems and methods
US6613004B1 (en) * 2000-04-21 2003-09-02 Insightec-Txsonics, Ltd. Systems and methods for creating longer necrosed volumes using a phased array focused ultrasound system
US6514250B1 (en) 2000-04-27 2003-02-04 Medtronic, Inc. Suction stabilized epicardial ablation devices
US6488680B1 (en) 2000-04-27 2002-12-03 Medtronic, Inc. Variable length electrodes for delivery of irrigated ablation
EP1278471B1 (en) 2000-04-27 2005-06-15 Medtronic, Inc. Vibration sensitive ablation apparatus
US6926669B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US20040138621A1 (en) 2003-01-14 2004-07-15 Jahns Scott E. Devices and methods for interstitial injection of biologic agents into tissue
US6699240B2 (en) 2001-04-26 2004-03-02 Medtronic, Inc. Method and apparatus for tissue ablation
US7250048B2 (en) 2001-04-26 2007-07-31 Medtronic, Inc. Ablation system and method of use
US6807968B2 (en) 2001-04-26 2004-10-26 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US6663627B2 (en) 2001-04-26 2003-12-16 Medtronic, Inc. Ablation system and method of use
US7959626B2 (en) 2001-04-26 2011-06-14 Medtronic, Inc. Transmural ablation systems and methods
US6648883B2 (en) 2001-04-26 2003-11-18 Medtronic, Inc. Ablation system and method of use
US20030013960A1 (en) 2001-05-29 2003-01-16 Makin Inder Raj. S. Guiding ultrasound end effector for medical treatment
US7211044B2 (en) 2001-05-29 2007-05-01 Ethicon Endo-Surgery, Inc. Method for mapping temperature rise using pulse-echo ultrasound
US7846096B2 (en) * 2001-05-29 2010-12-07 Ethicon Endo-Surgery, Inc. Method for monitoring of medical treatment using pulse-echo ultrasound
US6656175B2 (en) 2001-12-11 2003-12-02 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US6827715B2 (en) 2002-01-25 2004-12-07 Medtronic, Inc. System and method of performing an electrosurgical procedure
US7967816B2 (en) 2002-01-25 2011-06-28 Medtronic, Inc. Fluid-assisted electrosurgical instrument with shapeable electrode
US7294143B2 (en) 2002-05-16 2007-11-13 Medtronic, Inc. Device and method for ablation of cardiac tissue
US7118566B2 (en) 2002-05-16 2006-10-10 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US6824555B1 (en) 2002-07-22 2004-11-30 Uop Llc Combustion needle for medical applications
US6960225B1 (en) 2002-07-22 2005-11-01 Uop Llc Medical applications using microcombustion
US7083620B2 (en) 2002-10-30 2006-08-01 Medtronic, Inc. Electrosurgical hemostat
US7497857B2 (en) 2003-04-29 2009-03-03 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US7494467B2 (en) 2004-04-16 2009-02-24 Ethicon Endo-Surgery, Inc. Medical system having multiple ultrasound transducers or an ultrasound transducer and an RF electrode
US8333764B2 (en) 2004-05-12 2012-12-18 Medtronic, Inc. Device and method for determining tissue thickness and creating cardiac ablation lesions
ATE399579T1 (en) 2004-05-14 2008-07-15 Medtronic Inc SYSTEM FOR USING HIGH-INTENSITY FOCUSED ULTRASOUND TO FORM AN ABLATED AREA OF TISSUE
US7883468B2 (en) * 2004-05-18 2011-02-08 Ethicon Endo-Surgery, Inc. Medical system having an ultrasound source and an acoustic coupling medium
US7951095B2 (en) 2004-05-20 2011-05-31 Ethicon Endo-Surgery, Inc. Ultrasound medical system
US7473250B2 (en) 2004-05-21 2009-01-06 Ethicon Endo-Surgery, Inc. Ultrasound medical system and method
WO2005120377A1 (en) 2004-06-02 2005-12-22 Medtronic, Inc. Clamping ablation tool
WO2005120375A2 (en) 2004-06-02 2005-12-22 Medtronic, Inc. Loop ablation apparatus and method
DE602005021096D1 (en) 2004-06-02 2010-06-17 Medtronic Inc COMPOUND BIPOLAR ABLATION DEVICE
EP1750608B1 (en) 2004-06-02 2012-10-03 Medtronic, Inc. Ablation device with jaws
US7806839B2 (en) 2004-06-14 2010-10-05 Ethicon Endo-Surgery, Inc. System and method for ultrasound therapy using grating lobes
US8409219B2 (en) 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
US8663245B2 (en) 2004-06-18 2014-03-04 Medtronic, Inc. Device for occlusion of a left atrial appendage
US8926635B2 (en) * 2004-06-18 2015-01-06 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
US8750983B2 (en) 2004-09-20 2014-06-10 P Tech, Llc Therapeutic system
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US8690779B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Noninvasive aesthetic treatment for tightening tissue
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
KR20130080477A (en) 2004-10-06 2013-07-12 가이디드 테라피 시스템스, 엘.엘.씨. System of ultrasound treatment
US8663112B2 (en) 2004-10-06 2014-03-04 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US7833221B2 (en) 2004-10-22 2010-11-16 Ethicon Endo-Surgery, Inc. System and method for treatment of tissue using the tissue as a fiducial
US7452357B2 (en) 2004-10-22 2008-11-18 Ethicon Endo-Surgery, Inc. System and method for planning treatment of tissue
US10219815B2 (en) 2005-09-22 2019-03-05 The Regents Of The University Of Michigan Histotripsy for thrombolysis
US8057408B2 (en) 2005-09-22 2011-11-15 The Regents Of The University Of Michigan Pulsed cavitational ultrasound therapy
WO2007140331A2 (en) 2006-05-25 2007-12-06 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US8235902B2 (en) 2007-09-11 2012-08-07 Focus Surgery, Inc. System and method for tissue change monitoring during HIFU treatment
EP2227174B1 (en) 2007-12-28 2019-05-01 Salient Surgical Technologies, Inc. Fluid-assisted electrosurgical device
WO2009140359A2 (en) 2008-05-13 2009-11-19 Medtronic, Inc. Tissue lesion evaluation
CA3206234A1 (en) 2008-06-06 2009-12-10 Ulthera, Inc. A system and method for cosmetic treatment and imaging
DE102008038309A1 (en) * 2008-08-19 2010-02-25 Theuer, Axel E., Prof. Dr.-Ing. habil. Device for destruction of tumor cells or pathogens in the bloodstream
US9254168B2 (en) 2009-02-02 2016-02-09 Medtronic Advanced Energy Llc Electro-thermotherapy of tissue using penetrating microelectrode array
EP2398416B1 (en) 2009-02-23 2015-10-28 Medtronic Advanced Energy LLC Fluid-assisted electrosurgical device
US9061131B2 (en) 2009-08-17 2015-06-23 Histosonics, Inc. Disposable acoustic coupling medium container
US9901753B2 (en) 2009-08-26 2018-02-27 The Regents Of The University Of Michigan Ultrasound lithotripsy and histotripsy for using controlled bubble cloud cavitation in fractionating urinary stones
WO2011028603A2 (en) 2009-08-26 2011-03-10 The Regents Of The University Of Michigan Micromanipulator control arm for therapeutic and imaging ultrasound transducers
CN102497832B (en) 2009-09-08 2015-09-09 显著外科技术公司 For case assembly and the using method thereof of electro-surgical device, electrosurgical unit
US8539813B2 (en) 2009-09-22 2013-09-24 The Regents Of The University Of Michigan Gel phantoms for testing cavitational ultrasound (histotripsy) transducers
US9592090B2 (en) 2010-03-11 2017-03-14 Medtronic Advanced Energy Llc Bipolar electrosurgical cutter with position insensitive return electrode contact
US20110295249A1 (en) * 2010-05-28 2011-12-01 Salient Surgical Technologies, Inc. Fluid-Assisted Electrosurgical Devices, and Methods of Manufacture Thereof
US9138289B2 (en) 2010-06-28 2015-09-22 Medtronic Advanced Energy Llc Electrode sheath for electrosurgical device
US8906012B2 (en) 2010-06-30 2014-12-09 Medtronic Advanced Energy Llc Electrosurgical devices with wire electrode
US8920417B2 (en) 2010-06-30 2014-12-30 Medtronic Advanced Energy Llc Electrosurgical devices and methods of use thereof
US9023040B2 (en) 2010-10-26 2015-05-05 Medtronic Advanced Energy Llc Electrosurgical cutting devices
US20130261368A1 (en) 2011-09-23 2013-10-03 Alan N. Schwartz Non-invasive and minimally invasive and tightly targeted minimally invasive therapy methods and devices for parathyroid treatment
US11045246B1 (en) 2011-01-04 2021-06-29 Alan N. Schwartz Apparatus for effecting feedback of vaginal cavity physiology
US20130019374A1 (en) 2011-01-04 2013-01-24 Schwartz Alan N Gel-based seals and fixation devices and associated systems and methods
US9427281B2 (en) 2011-03-11 2016-08-30 Medtronic Advanced Energy Llc Bronchoscope-compatible catheter provided with electrosurgical device
US9144694B2 (en) 2011-08-10 2015-09-29 The Regents Of The University Of Michigan Lesion generation through bone using histotripsy therapy without aberration correction
US9750565B2 (en) 2011-09-30 2017-09-05 Medtronic Advanced Energy Llc Electrosurgical balloons
US8870864B2 (en) 2011-10-28 2014-10-28 Medtronic Advanced Energy Llc Single instrument electrosurgery apparatus and its method of use
US9107737B2 (en) 2011-11-21 2015-08-18 Alan Schwartz Goggles with facial conforming eyepieces
US9049783B2 (en) 2012-04-13 2015-06-02 Histosonics, Inc. Systems and methods for obtaining large creepage isolation on printed circuit boards
WO2013166019A1 (en) 2012-04-30 2013-11-07 The Regents Of The University Of Michigan Ultrasound transducer manufacturing using rapid-prototyping method
WO2013173810A2 (en) 2012-05-17 2013-11-21 Schwartz Alan N Localization of the parathyroid
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
EP2903688A4 (en) 2012-10-05 2016-06-15 Univ Michigan Bubble-induced color doppler feedback during histotripsy
CN204017181U (en) 2013-03-08 2014-12-17 奥赛拉公司 Aesthstic imaging and processing system, multifocal processing system and perform the system of aesthetic procedure
US11432900B2 (en) 2013-07-03 2022-09-06 Histosonics, Inc. Articulating arm limiter for cavitational ultrasound therapy system
ES2941665T3 (en) 2013-07-03 2023-05-24 Histosonics Inc Optimized history excitation sequences for bubble cloud formation using shock scattering
WO2015027164A1 (en) 2013-08-22 2015-02-26 The Regents Of The University Of Michigan Histotripsy using very short ultrasound pulses
WO2015160708A1 (en) 2014-04-18 2015-10-22 Ulthera, Inc. Band transducer ultrasound therapy
US9974599B2 (en) 2014-08-15 2018-05-22 Medtronic Ps Medical, Inc. Multipurpose electrosurgical device
ES2948135T3 (en) 2015-06-24 2023-08-31 Univ Michigan Regents Histotripsy therapy systems for the treatment of brain tissue
US11389227B2 (en) 2015-08-20 2022-07-19 Medtronic Advanced Energy Llc Electrosurgical device with multivariate control
US11051875B2 (en) 2015-08-24 2021-07-06 Medtronic Advanced Energy Llc Multipurpose electrosurgical device
US10716612B2 (en) 2015-12-18 2020-07-21 Medtronic Advanced Energy Llc Electrosurgical device with multiple monopolar electrode assembly
PL3405294T3 (en) 2016-01-18 2023-05-08 Ulthera, Inc. Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board
IL293809B2 (en) 2016-08-16 2023-09-01 Ulthera Inc Systems and methods for cosmetic ultrasound treatment of skin
US10194975B1 (en) 2017-07-11 2019-02-05 Medtronic Advanced Energy, Llc Illuminated and isolated electrosurgical apparatus
WO2019164836A1 (en) 2018-02-20 2019-08-29 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
US11813484B2 (en) 2018-11-28 2023-11-14 Histosonics, Inc. Histotripsy systems and methods
US11813485B2 (en) 2020-01-28 2023-11-14 The Regents Of The University Of Michigan Systems and methods for histotripsy immunosensitization

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB820814A (en) * 1955-12-22 1959-09-30 Univ Illinois Apparatus for treating living tissue
US3735755A (en) * 1971-06-28 1973-05-29 Interscience Research Inst Noninvasive surgery method and apparatus
EP0045265A2 (en) * 1980-07-29 1982-02-03 Jacques Dory Probe for echography with sectional mechanical scanning
EP0370841A1 (en) * 1988-10-27 1990-05-30 Edap International Ultrasound treatment apparatus using a focalizing and oscillating piezoelectric ceramic device
FR2664819A1 (en) * 1990-07-23 1992-01-24 Edap Int ULTRA-FAST EXTRACORPOREAL ULTRASONIC HYPERTHERMAL APPARATUS.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR370841A (en) * 1906-10-26 1907-02-20 Martin Krimnitz Alarm clock with repeating ringing
JPS4911583B1 (en) * 1970-09-03 1974-03-18
US5150711A (en) * 1983-12-14 1992-09-29 Edap International, S.A. Ultra-high-speed extracorporeal ultrasound hyperthermia treatment device
US5143074A (en) * 1983-12-14 1992-09-01 Edap International Ultrasonic treatment device using a focussing and oscillating piezoelectric element
JPS61209643A (en) * 1985-03-15 1986-09-17 株式会社東芝 Ultrasonic diagnostic and medical treatment apparatus
US4955365A (en) * 1988-03-02 1990-09-11 Laboratory Equipment, Corp. Localization and therapy system for treatment of spatially oriented focal disease
JPH02161936A (en) * 1988-12-14 1990-06-21 Toshiba Corp Impulse wave treatment device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB820814A (en) * 1955-12-22 1959-09-30 Univ Illinois Apparatus for treating living tissue
US3735755A (en) * 1971-06-28 1973-05-29 Interscience Research Inst Noninvasive surgery method and apparatus
EP0045265A2 (en) * 1980-07-29 1982-02-03 Jacques Dory Probe for echography with sectional mechanical scanning
EP0370841A1 (en) * 1988-10-27 1990-05-30 Edap International Ultrasound treatment apparatus using a focalizing and oscillating piezoelectric ceramic device
FR2664819A1 (en) * 1990-07-23 1992-01-24 Edap Int ULTRA-FAST EXTRACORPOREAL ULTRASONIC HYPERTHERMAL APPARATUS.

Also Published As

Publication number Publication date
BR9300021A (en) 1993-07-13
CN1076128A (en) 1993-09-15
FR2685872A1 (en) 1993-07-09
CA2086772A1 (en) 1993-07-08
JPH0678944A (en) 1994-03-22
IL104216A0 (en) 1993-05-13
US5354258A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
US5354258A (en) Ultra-high-speed extracorporeal ultrasound hyperthermia treatment method
US5150711A (en) Ultra-high-speed extracorporeal ultrasound hyperthermia treatment device
US9272162B2 (en) Imaging, therapy, and temperature monitoring ultrasonic method
Child et al. Lung damage from exposure to pulsed ultrasound
US5080102A (en) Examining, localizing and treatment with ultrasound
US6500121B1 (en) Imaging, therapy, and temperature monitoring ultrasonic system
US6623430B1 (en) Method and apparatus for safety delivering medicants to a region of tissue using imaging, therapy and temperature monitoring ultrasonic system
US6488639B1 (en) Frequency adjustment in high intensity focused ultrasound treatment apparatus
EP0661029B1 (en) Apparatus for ultrasonic medical treatment with optimum ultrasonic irradiation control
EP0194897B1 (en) Ultrasound therapy system
US6361500B1 (en) Three transducer catheter
US6334846B1 (en) Ultrasound therapeutic apparatus
US5150712A (en) Apparatus for examining and localizing tumors using ultra sounds, comprising a device for localized hyperthermia treatment
EP1803403B1 (en) Ultrasound diagnostic system of detecting a lesion
EP0170416A1 (en) Ultrasound hyperthermia apparatus
JP3063923B2 (en) Extracorporeal ultrasonic high-temperature treatment apparatus and method for setting its parameters
US5921930A (en) Arrangement for locating concrements in a patient's body
Stanghvi et al. Ultrasound intracavity system for imaging, therapy planning and treatment of focal disease
US20130301382A1 (en) Method and Device for Ultrasound Imaging
JPH0779824B2 (en) Ultrasonic treatment device using a convergent / oscillating piezoelectric ceramic
JPH0824268A (en) Impulse wave treating apparatus and thermal treating apparatus
JP3145084B2 (en) Ultrasound therapy equipment
JP3015440B2 (en) Shock wave therapy device and thermal therapy device
JPH08164135A (en) Heavy duty ultrasonic beam irradiation method and ultrasonic wave irradiation treatment device used in the same
JPH0592008A (en) Impulse wave medical treatment device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19960830

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970311